Results 231 to 240 of about 2,786,772 (398)
Porous silicon nanoparticles (PSiNPs) reprogram macrophage endocytosis of manganese@albumin‐based TLR4 nanoagonists, driving TRIF‐biased TLR4 signaling, eliciting robust proinflammatory responses, and potentiating macrophage‐mediated immunotherapeutic effects against NSCLC.
Xiaomei Zhang +9 more
wiley +1 more source
Basal Cell Carcinoma with Sarcomatoid Differentiation-A Rare Type and Its Possible Origin. [PDF]
Abu Rached N +4 more
europepmc +1 more source
The pre‐internalization phase of endocytosis remains poorly characterized at single‐cell levels. Single‐cell pre‐internalization mechanics are investigated using advanced robotic techniques. Cancer cells exhibit biphasic adhesion – rapid initial binding followed by reinforcement – while fibroblasts show gradual engagement.
Houari Bettahar +6 more
wiley +1 more source
Cumulative Sum Analysis-Integrated E-Learning for Differentiation Between Basal Cell Carcinoma and Non-Basal Cell Carcinoma on Optical Coherence Tomography: An Observational Cohort Study. [PDF]
Wolswijk T +7 more
europepmc +1 more source
Lectin-binding sites in basal cell epitheliomas and carcinomas.
KYUNG-HWAH YUN +4 more
openalex +2 more sources
FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma
Denise Casey +9 more
semanticscholar +1 more source
Metal Nanoclusters for Cancer Imaging and Treatment
This review aims to provide a comprehensive summary and discussion of the core–shell design capabilities of metal nanoclusters (NCs) at the atomic level for cancer imaging and treatment. It offers essential insights into the design principles of metal NCs while also encouraging the exploration of other nanomaterials and their potential theranostic ...
Haiguang Zhu +5 more
wiley +1 more source
Metastatic basal cell carcinoma: Case series and literature review. [PDF]
Rodrigues MG +6 more
europepmc +1 more source
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao +8 more
wiley +1 more source
Past Marks: A Case Report of Basal Cell Carcinoma Induced by Arsenic Exposure. [PDF]
Carreira P +4 more
europepmc +1 more source

